The global Nuclear Medicine market size was valued at USD 6368.4 million in 2022 and is forecast to a readjusted size of USD 10280 million by 2029 with a CAGR of 7.1% during review period.
Nuclear Medicine, or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second-place consumption region with the consumption market share of about 25%. Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share. The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%. Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
This report is a detailed and comprehensive analysis for global Nuclear Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nuclear Medicine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nuclear Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nuclear Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Nuclear Medicine market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nuclear Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nuclear Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Diagnostic
Therapeutic
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Nuclear Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nuclear Medicine, with revenue, gross margin and global market share of Nuclear Medicine from 2018 to 2023.
Chapter 3, the Nuclear Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nuclear Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nuclear Medicine.
Chapter 13, to describe Nuclear Medicine research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Nuclear Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nuclear Medicine by Type
1.3.1 Overview: Global Nuclear Medicine Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Nuclear Medicine Consumption Value Market Share by Type in 2022
1.3.3 Tc-99
1.3.4 I-123/131
1.3.5 In-111
1.3.6 Xe-133
1.3.7 Th-201
1.3.8 Ga-67
1.3.9 Others
1.4 Global Nuclear Medicine Market by Application
1.4.1 Overview: Global Nuclear Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diagnostic
1.4.3 Therapeutic
1.5 Global Nuclear Medicine Market Size & Forecast
1.6 Global Nuclear Medicine Market Size and Forecast by Region
1.6.1 Global Nuclear Medicine Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Nuclear Medicine Market Size by Region, (2018-2029)
1.6.3 North America Nuclear Medicine Market Size and Prospect (2018-2029)
1.6.4 Europe Nuclear Medicine Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Nuclear Medicine Market Size and Prospect (2018-2029)
1.6.6 South America Nuclear Medicine Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Nuclear Medicine Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Nuclear Medicine Product and Solutions
2.1.4 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GE Healthcare Recent Developments and Future Plans
2.2 Bracco Imaging
2.2.1 Bracco Imaging Details
2.2.2 Bracco Imaging Major Business
2.2.3 Bracco Imaging Nuclear Medicine Product and Solutions
2.2.4 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bracco Imaging Recent Developments and Future Plans
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Nuclear Medicine Product and Solutions
2.3.4 Mallinckrodt Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mallinckrodt Recent Developments and Future Plans
2.4 Lantheus Medical Imaging
2.4.1 Lantheus Medical Imaging Details
2.4.2 Lantheus Medical Imaging Major Business
2.4.3 Lantheus Medical Imaging Nuclear Medicine Product and Solutions
2.4.4 Lantheus Medical Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lantheus Medical Imaging Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Nuclear Medicine Product and Solutions
2.5.4 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Recent Developments and Future Plans
2.6 Triad Isotopes
2.6.1 Triad Isotopes Details
2.6.2 Triad Isotopes Major Business
2.6.3 Triad Isotopes Nuclear Medicine Product and Solutions
2.6.4 Triad Isotopes Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Triad Isotopes Recent Developments and Future Plans
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Nuclear Medicine Product and Solutions
2.7.4 Nordion Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Nordion Recent Developments and Future Plans
2.8 Jubilant Pharma
2.8.1 Jubilant Pharma Details
2.8.2 Jubilant Pharma Major Business
2.8.3 Jubilant Pharma Nuclear Medicine Product and Solutions
2.8.4 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jubilant Pharma Recent Developments and Future Plans
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Nuclear Medicine Product and Solutions
2.9.4 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eli Lilly Recent Developments and Future Plans
2.10 SIEMENS
2.10.1 SIEMENS Details
2.10.2 SIEMENS Major Business
2.10.3 SIEMENS Nuclear Medicine Product and Solutions
2.10.4 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SIEMENS Recent Developments and Future Plans
2.11 China Isotope & Radiation
2.11.1 China Isotope & Radiation Details
2.11.2 China Isotope & Radiation Major Business
2.11.3 China Isotope & Radiation Nuclear Medicine Product and Solutions
2.11.4 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 China Isotope & Radiation Recent Developments and Future Plans
2.12 Dongcheng
2.12.1 Dongcheng Details
2.12.2 Dongcheng Major Business
2.12.3 Dongcheng Nuclear Medicine Product and Solutions
2.12.4 Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Dongcheng Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nuclear Medicine Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Nuclear Medicine by Company Revenue
3.2.2 Top 3 Nuclear Medicine Players Market Share in 2022
3.2.3 Top 6 Nuclear Medicine Players Market Share in 2022
3.3 Nuclear Medicine Market: Overall Company Footprint Analysis
3.3.1 Nuclear Medicine Market: Region Footprint
3.3.2 Nuclear Medicine Market: Company Product Type Footprint
3.3.3 Nuclear Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Nuclear Medicine Consumption Value and Market Share by Type (2018-2023)
4.2 Global Nuclear Medicine Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Nuclear Medicine Consumption Value Market Share by Application (2018-2023)
5.2 Global Nuclear Medicine Market Forecast by Application (2024-2029)
6 North America
6.1 North America Nuclear Medicine Consumption Value by Type (2018-2029)
6.2 North America Nuclear Medicine Consumption Value by Application (2018-2029)
6.3 North America Nuclear Medicine Market Size by Country
6.3.1 North America Nuclear Medicine Consumption Value by Country (2018-2029)
6.3.2 United States Nuclear Medicine Market Size and Forecast (2018-2029)
6.3.3 Canada Nuclear Medicine Market Size and Forecast (2018-2029)
6.3.4 Mexico Nuclear Medicine Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Nuclear Medicine Consumption Value by Type (2018-2029)
7.2 Europe Nuclear Medicine Consumption Value by Application (2018-2029)
7.3 Europe Nuclear Medicine Market Size by Country
7.3.1 Europe Nuclear Medicine Consumption Value by Country (2018-2029)
7.3.2 Germany Nuclear Medicine Market Size and Forecast (2018-2029)
7.3.3 France Nuclear Medicine Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Nuclear Medicine Market Size and Forecast (2018-2029)
7.3.5 Russia Nuclear Medicine Market Size and Forecast (2018-2029)
7.3.6 Italy Nuclear Medicine Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Nuclear Medicine Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Nuclear Medicine Market Size by Region
8.3.1 Asia-Pacific Nuclear Medicine Consumption Value by Region (2018-2029)
8.3.2 China Nuclear Medicine Market Size and Forecast (2018-2029)
8.3.3 Japan Nuclear Medicine Market Size and Forecast (2018-2029)
8.3.4 South Korea Nuclear Medicine Market Size and Forecast (2018-2029)
8.3.5 India Nuclear Medicine Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Nuclear Medicine Market Size and Forecast (2018-2029)
8.3.7 Australia Nuclear Medicine Market Size and Forecast (2018-2029)
9 South America
9.1 South America Nuclear Medicine Consumption Value by Type (2018-2029)
9.2 South America Nuclear Medicine Consumption Value by Application (2018-2029)
9.3 South America Nuclear Medicine Market Size by Country
9.3.1 South America Nuclear Medicine Consumption Value by Country (2018-2029)
9.3.2 Brazil Nuclear Medicine Market Size and Forecast (2018-2029)
9.3.3 Argentina Nuclear Medicine Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Nuclear Medicine Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Nuclear Medicine Market Size by Country
10.3.1 Middle East & Africa Nuclear Medicine Consumption Value by Country (2018-2029)
10.3.2 Turkey Nuclear Medicine Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Nuclear Medicine Market Size and Forecast (2018-2029)
10.3.4 UAE Nuclear Medicine Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Nuclear Medicine Market Drivers
11.2 Nuclear Medicine Market Restraints
11.3 Nuclear Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Nuclear Medicine Industry Chain
12.2 Nuclear Medicine Upstream Analysis
12.3 Nuclear Medicine Midstream Analysis
12.4 Nuclear Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nuclear Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Nuclear Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Nuclear Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 5. GE Healthcare Company Information, Head Office, and Major Competitors
Table 6. GE Healthcare Major Business
Table 7. GE Healthcare Nuclear Medicine Product and Solutions
Table 8. GE Healthcare Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. GE Healthcare Recent Developments and Future Plans
Table 10. Bracco Imaging Company Information, Head Office, and Major Competitors
Table 11. Bracco Imaging Major Business
Table 12. Bracco Imaging Nuclear Medicine Product and Solutions
Table 13. Bracco Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bracco Imaging Recent Developments and Future Plans
Table 15. Mallinckrodt Company Information, Head Office, and Major Competitors
Table 16. Mallinckrodt Major Business
Table 17. Mallinckrodt Nuclear Medicine Product and Solutions
Table 18. Mallinckrodt Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Mallinckrodt Recent Developments and Future Plans
Table 20. Lantheus Medical Imaging Company Information, Head Office, and Major Competitors
Table 21. Lantheus Medical Imaging Major Business
Table 22. Lantheus Medical Imaging Nuclear Medicine Product and Solutions
Table 23. Lantheus Medical Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Lantheus Medical Imaging Recent Developments and Future Plans
Table 25. Bayer Company Information, Head Office, and Major Competitors
Table 26. Bayer Major Business
Table 27. Bayer Nuclear Medicine Product and Solutions
Table 28. Bayer Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bayer Recent Developments and Future Plans
Table 30. Triad Isotopes Company Information, Head Office, and Major Competitors
Table 31. Triad Isotopes Major Business
Table 32. Triad Isotopes Nuclear Medicine Product and Solutions
Table 33. Triad Isotopes Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Triad Isotopes Recent Developments and Future Plans
Table 35. Nordion Company Information, Head Office, and Major Competitors
Table 36. Nordion Major Business
Table 37. Nordion Nuclear Medicine Product and Solutions
Table 38. Nordion Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Nordion Recent Developments and Future Plans
Table 40. Jubilant Pharma Company Information, Head Office, and Major Competitors
Table 41. Jubilant Pharma Major Business
Table 42. Jubilant Pharma Nuclear Medicine Product and Solutions
Table 43. Jubilant Pharma Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Jubilant Pharma Recent Developments and Future Plans
Table 45. Eli Lilly Company Information, Head Office, and Major Competitors
Table 46. Eli Lilly Major Business
Table 47. Eli Lilly Nuclear Medicine Product and Solutions
Table 48. Eli Lilly Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Eli Lilly Recent Developments and Future Plans
Table 50. SIEMENS Company Information, Head Office, and Major Competitors
Table 51. SIEMENS Major Business
Table 52. SIEMENS Nuclear Medicine Product and Solutions
Table 53. SIEMENS Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. SIEMENS Recent Developments and Future Plans
Table 55. China Isotope & Radiation Company Information, Head Office, and Major Competitors
Table 56. China Isotope & Radiation Major Business
Table 57. China Isotope & Radiation Nuclear Medicine Product and Solutions
Table 58. China Isotope & Radiation Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. China Isotope & Radiation Recent Developments and Future Plans
Table 60. Dongcheng Company Information, Head Office, and Major Competitors
Table 61. Dongcheng Major Business
Table 62. Dongcheng Nuclear Medicine Product and Solutions
Table 63. Dongcheng Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Dongcheng Recent Developments and Future Plans
Table 65. Global Nuclear Medicine Revenue (USD Million) by Players (2018-2023)
Table 66. Global Nuclear Medicine Revenue Share by Players (2018-2023)
Table 67. Breakdown of Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Nuclear Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Nuclear Medicine Players
Table 70. Nuclear Medicine Market: Company Product Type Footprint
Table 71. Nuclear Medicine Market: Company Product Application Footprint
Table 72. Nuclear Medicine New Market Entrants and Barriers to Market Entry
Table 73. Nuclear Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Nuclear Medicine Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Nuclear Medicine Consumption Value Share by Type (2018-2023)
Table 76. Global Nuclear Medicine Consumption Value Forecast by Type (2024-2029)
Table 77. Global Nuclear Medicine Consumption Value by Application (2018-2023)
Table 78. Global Nuclear Medicine Consumption Value Forecast by Application (2024-2029)
Table 79. North America Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Nuclear Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Nuclear Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Nuclear Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Nuclear Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Nuclear Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Nuclear Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Nuclear Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Nuclear Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Nuclear Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Nuclear Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Nuclear Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Nuclear Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Nuclear Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Nuclear Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Nuclear Medicine Raw Material
Table 110. Key Suppliers of Nuclear Medicine Raw Materials
List of Figures
Figure 1. Nuclear Medicine Picture
Figure 2. Global Nuclear Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nuclear Medicine Consumption Value Market Share by Type in 2022
Figure 4. Tc-99
Figure 5. I-123/131
Figure 6. In-111
Figure 7. Xe-133
Figure 8. Th-201
Figure 9. Ga-67
Figure 10. Others
Figure 11. Global Nuclear Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 12. Nuclear Medicine Consumption Value Market Share by Application in 2022
Figure 13. Diagnostic Picture
Figure 14. Therapeutic Picture
Figure 15. Global Nuclear Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Nuclear Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Nuclear Medicine Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Nuclear Medicine Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Nuclear Medicine Consumption Value Market Share by Region in 2022
Figure 20. North America Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Nuclear Medicine Revenue Share by Players in 2022
Figure 26. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Nuclear Medicine Market Share in 2022
Figure 28. Global Top 6 Players Nuclear Medicine Market Share in 2022
Figure 29. Global Nuclear Medicine Consumption Value Share by Type (2018-2023)
Figure 30. Global Nuclear Medicine Market Share Forecast by Type (2024-2029)
Figure 31. Global Nuclear Medicine Consumption Value Share by Application (2018-2023)
Figure 32. Global Nuclear Medicine Market Share Forecast by Application (2024-2029)
Figure 33. North America Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Nuclear Medicine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Nuclear Medicine Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 43. France Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Nuclear Medicine Consumption Value Market Share by Region (2018-2029)
Figure 50. China Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 53. India Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Nuclear Medicine Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Nuclear Medicine Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Nuclear Medicine Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Nuclear Medicine Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Nuclear Medicine Consumption Value (2018-2029) & (USD Million)
Figure 67. Nuclear Medicine Market Drivers
Figure 68. Nuclear Medicine Market Restraints
Figure 69. Nuclear Medicine Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Nuclear Medicine in 2022
Figure 72. Manufacturing Process Analysis of Nuclear Medicine
Figure 73. Nuclear Medicine Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
